aTYR PHARMA INC (ATYR) Net margin 2019–2025
aTYR PHARMA INC (ATYR) net profit margin by fiscal year — reported net income divided by reported revenue.
-39009.5%FY2025 · since FY2019: -3844.5% → -39009.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -39009.5% | -11765.6 pp |
| FY2024 | -27243.8% | -12969.3 pp |
| FY2023 | -14274.5% | -13838.0 pp |
| FY2022 | -436.5% | — |
| FY2020 | -155.2% | +3689.4 pp |
| FY2019 | -3844.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ATYR financial trends
ATYR RevenueATYR Net incomeATYR Gross profitATYR Gross marginATYR Operating incomeATYR Operating marginATYR Operating cash flowATYR Free cash flowATYR Capital expendituresATYR Return on equityATYR Stock buybacksATYR Dividends paidATYR Total assetsATYR Total liabilitiesATYR Shareholders’ equityATYR overview →